Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A De Man

Showing results (411-420 of 480) with videos related to

Pageof 48
Sort By:
Lancet (London, England)|July 8, 1998
Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigenF ter Borg, F J ten Kate, H T Cuypers, et al.
Journal of Hepatology|May 21, 2019
The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort studyJohann von Felden, Laurent Alric, Sven Pischke, et al.
Journal of Hepatology|July 22, 2014
Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumaratePatrick Marcellin, Maria Buti, Zahari Krastev, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2022
Safety and Efficacy of <sup>166</sup>Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary StudyMargot T M Reinders, Karel J van Erpecum, Maarten L J Smits, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2024
Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical TrialsEdo J Dongelmans, Jordan J Feld, André Boonstra, et al.
Frontiers in Immunology|October 2, 2023
Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides <i>ex vivo</i>Diahann T S L Jansen, Monique T A de Beijer, Robbie J Luijten, et al.
Journal of Clinical Pathology|August 29, 2000
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individualsF ter Borg, F J ten Kate, H T Cuypers, et al.
Antiviral Research|February 22, 2020
Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patientsYingying Dou, Diahann T S L Jansen, Aniek van den Bosch, et al.
Journal of Hepatology|June 24, 2015
Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the NetherlandsSuzanne van Meer, Robert A de Man, Minneke J Coenraad, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 13, 2020
A multicentre retrospective analysis on growth of residual hepatocellular adenoma after resectionAnne J Klompenhouwer, Belle V van Rosmalen, Martijn P D Haring, et al.
Pageof 48

Showing results (411-420 of 480) with videos related to

Sort By:
Pageof 48
Lancet (London, England)|July 8, 1998
Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigenF ter Borg, F J ten Kate, H T Cuypers, et al.
Journal of Hepatology|May 21, 2019
The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort studyJohann von Felden, Laurent Alric, Sven Pischke, et al.
Journal of Hepatology|July 22, 2014
Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumaratePatrick Marcellin, Maria Buti, Zahari Krastev, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2022
Safety and Efficacy of <sup>166</sup>Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary StudyMargot T M Reinders, Karel J van Erpecum, Maarten L J Smits, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2024
Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical TrialsEdo J Dongelmans, Jordan J Feld, André Boonstra, et al.
Frontiers in Immunology|October 2, 2023
Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides <i>ex vivo</i>Diahann T S L Jansen, Monique T A de Beijer, Robbie J Luijten, et al.
Journal of Clinical Pathology|August 29, 2000
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individualsF ter Borg, F J ten Kate, H T Cuypers, et al.
Antiviral Research|February 22, 2020
Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patientsYingying Dou, Diahann T S L Jansen, Aniek van den Bosch, et al.
Journal of Hepatology|June 24, 2015
Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the NetherlandsSuzanne van Meer, Robert A de Man, Minneke J Coenraad, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 13, 2020
A multicentre retrospective analysis on growth of residual hepatocellular adenoma after resectionAnne J Klompenhouwer, Belle V van Rosmalen, Martijn P D Haring, et al.
Pageof 48